Catalent Pharma pumps HY to fund M&A
US drugs specialist Catalent Pharma on Tuesday began offering its debut euro bond to investors as it sought funding for its acquisition of peers Pharmatek and Accucaps.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: